浏览全部资源
扫码关注微信
1.浙江中医药大学 附属第一医院(浙江省中医院),杭州 310006
2.上海市浦东新区光明中医医院,上海 201399
3.上海中医药大学 附属曙光医院,上海 201203
郑屿萍,硕士,医师,从事中西医结合治疗皮肤病性病研究,E-mail:zypinsistence@163.com
何翔,主任医师,教授,从事中西医结合治疗皮肤病性病研究,E-mail:heroxiang@hotmail.com
收稿日期:2024-11-21,
录用日期:2025-02-28,
网络出版日期:2025-04-18,
纸质出版日期:2025-07-20
移动端阅览
郑屿萍,张彦峰,耿兰馨等.复方狼毒酊干预湿毒蕴结型多发性掌跖疣的临床疗效及机制探讨[J].中国实验方剂学杂志,2025,31(14):129-136.
ZHENG Yuping,ZHANG Yanfeng,GENG Lanxin,et al.Clinical Efficacy and Mechanism of Compound Langdu Tincture in Treating Multiple Palmoplantar Warts of Dampness-toxin Accumulation Type[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(14):129-136.
郑屿萍,张彦峰,耿兰馨等.复方狼毒酊干预湿毒蕴结型多发性掌跖疣的临床疗效及机制探讨[J].中国实验方剂学杂志,2025,31(14):129-136. DOI: 10.13422/j.cnki.syfjx.20251497.
ZHENG Yuping,ZHANG Yanfeng,GENG Lanxin,et al.Clinical Efficacy and Mechanism of Compound Langdu Tincture in Treating Multiple Palmoplantar Warts of Dampness-toxin Accumulation Type[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(14):129-136. DOI: 10.13422/j.cnki.syfjx.20251497.
目的
2
观察复方狼毒酊干预湿毒蕴结型多发性掌跖疣的临床疗效,并基于网络药理学和实验验证探讨复方狼毒酊治疗多发性掌跖疣的潜在机制。
方法
2
采用前瞻性随机对照单盲的试验设计,将76例多发性掌跖疣患者按照随机数字表法随机分为两组,每组各38例,观察组外用复方狼毒酊,对照组外用15%水杨酸软膏。分别对比患者治疗前后皮损清除率、疗效总愈显率、疗效总有效率、皮损数量、大小、面积、厚度、疼痛程度、皮肤病生活质量指数(DLQI)评分,并对安全性和复发情况进行分析。通过中药系统药理学数据库和分析平台(TCMSP)数据库筛选出药物成分;通过人类孟德尔遗传综合数据库(OMIM)、Genecards中检索疾病相关基因。构建蛋白质-蛋白质相互作用(PPI)网络并进行基因本体(GO)、京都基因与基因组百科全书(KEGG)富集分析。运用实时荧光定量聚合酶链式反应(Real-time PCR)对关键靶点进行验证。
结果
2
治疗前,两组患者在皮损数量、大小、面积、厚度、疼痛程度、DLQI评分方面比较差异无统计学意义。与本组治疗前比较,两组患者治疗后皮损清除率、总愈显率、总有效率、数量、大小、面积、厚度、疼痛程度及DLQI评分均较治疗前明显好转(
P
<
0.05),且观察组全程中均未发现严重不良反应。与对照组治疗后比较,观察组患者在皮损清除率、皮损数量、疼痛程度评分更优(
P
<
0.05)。网络药理学结果显示,复方狼毒酊可能作用于蛋白激酶B1(Akt1)、表皮生长因子受体(EGFR)、肿瘤蛋白(TP53)等靶点,通过Janus酪氨酸蛋白激酶(JAK)/信号转导及转录激活因子(STAT)信号通路、磷脂酰肌醇3-激酶(PI3K)/Akt等信号通路发挥治疗作用。与治疗前比较,治疗12周后患者皮损组织中Akt1、EGFR mRNA表达下调,TP53的mRNA表达上调(
P
<
0.05)。
结论
2
复方狼毒酊治疗湿毒蕴结型多发性掌跖疣临床疗效确切。网络药理学初步揭示了其作用机制,通过Real-time PCR 对关键靶点进行了验证,为后续实验研究提供依据。
Objective
2
To observe the clinical efficacy of compound Langdu tincture in the treatment of multiple palmoplantar warts of dampness-toxin accumulation type and explore the potential treatment mechanism based on network pharmacology and experimental verification.
Methods
2
A prospective randomized controlled single-blind trial design was adopted. Seventy-six patients with multiple palmoplantar warts were assigned into two groups according to the random number table method, with 38 patients in each group. The observation group was treated with compound Langdu tincture, and the control group was treated with 15% salicylic acid ointment. The skin lesion clearance rate, cured and marked response rate, total response rate, skin lesion number, skin lesion size, skin lesion area, skin lesion thickness, pain degree, and Dermatology Life Quality Index (DLQI) were compared before and after treatment, and the safety and recurrence were analyzed. The drug components were screened out from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). Disease-related genes were retrieved from Online Mendelian Inheritance in Man (OMIM) and Genecards. The protein-protein interaction (PPI) network was constructed and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed. The key targets were verified by Real-time PCR.
Results
2
Before treatment, there was no significant difference in the skin lesion number, skin lesion size, skin lesion area, skin lesion thickness, pain degree or DLQI between the two groups. After treatment, both groups were improved in terms of the skin lesion clearance rate, cured and marked response rate, total response rate, skin lesion number, skin lesion size, skin lesion area, skin lesion thickness, pain degree, and DLQI (
P<
0.05), and no serious adverse reaction was observed in the observation group. Furthermore, the observation was superior to the control group regarding the skin lesion clearance rate, skin lesion number, and pain degree (
P<
0.05). The results of network pharmacology showed that compound Langdu tincture may act on targets such as protein kinase B1 (Akt1), epidermal growth factor receptor (EGFR), tumor protein p53 (TP53) to play a therapeutic role via the Janus kinase (JAK)/signal transducer and activator of transcription (STAT), phosphatidylinositol 3-kinase (PI3K)/Akt and other signaling pathways. The mRNA levels of Akt1 and EGFR were down-regulated and that of TP53 was up-regulated in the skin lesions of patients after 12 weeks of treatment.
Conclusion
2
Compound Langdu tincture has a definite clinical effect on multiple palmoplantar warts of the dampness-toxin accumulation type. The network pharmacology preliminarily revealed the treatment mechanism, and the key targets were verified by Real-time PCR, which provided a basis for subsequent experimental research.
LIU X , XI R , CHENG L , et al . Effectiveness and mechanism of the Chinese medicine Weiren Xiaoyou formula in improving palmoplantar warts [J]. Heliyon , 2024 , 10 ( 10 ): e31376 .
WITCHEY D J , WITCHEY N B , ROTH-KAUFFMAN M M , et al . Plantar warts:Epidemiology,pathophysiology,and clinical management [J]. J Am Osteopath Assoc , 2018 , 118 ( 2 ): 92 - 105 .
ZHU P , QI R Q , YANG Y , et al . Clinical guideline for the diagnosis and treatment of cutaneous warts(2022) [J]. J Evid Based Med , 2022 , 15 ( 3 ): 284 - 301 .
SHAHMORADI Z , ASSAF F , AL SAID H , et al . Topical pyruvic acid(70%) versus topical salicylic acid(16.7%) compound in treatment of plantar warts:A randomized controlled trial [J]. Adv Biomed Res , 2015 , 4 : 113 .
KWOK C S , HOLLAND R , GIBBS S . Efficacy of topical treatments for cutaneous warts:A Meta-analysis and pooled analysis of randomized controlled trials [J]. Br J Dermatol , 2011 , 165 ( 2 ): 233 - 246 .
HOOD C R , MILLER J R . The ring verruca plantaris in cantharidin use(a case report) [J]. J Am Podiatr Med Assoc , 2018 , 108 ( 2 ): 189 - 193 .
ARMOUR K , ORCHARD D . Treatment of palmoplantar warts with a diphencyprone and salicylic acid ointment [J]. Australas J Dermatol , 2006 , 47 ( 3 ): 182 - 185 .
HE X , XU P , HE X F , et al . Efficacy of topical administration of Radix Euphorbiae Ebracteolatae on multiple plantar warts:A parallel randomized trial [J]. Chin J Integr Med , 2017 ,
杨志波 , 范瑞强 , 邓丙戍 . 中医皮肤性病学 [M]. 4版 . 北京 : 中国中医药出版社 , 2010 .
YANG Z B , FAN R Q , DENG B S . Dermatology and venereology of traditional Chinese medicine [M]. 4 th ed . Beijing : China Traditional Chinese Medicine Press , 2010 .
杜立平 , 王东升 . 2015年版《中国药典》(一部)毒性药材及饮片的归纳分析 [J]. 中国药房 , 2017 , 28 ( 28 ): 4023 - 4026 .
DU L P , WANG D S . Induction analysis of toxic herbs and decoction pieces in Chinese Pharmacopoeia (2015 Edition,Part 1) [J]. China Pharm , 2017 , 28 ( 28 ): 4023 - 4026 .
张朝玉 , 应小平 . 《神农本草经》抗肿瘤中药统计分析 [J]. 国医论坛 , 2016 , 31 ( 5 ): 58 - 60 .
ZHANG C Y , YING X P . Statistical analysis of anti-tumor traditional Chinese medicine Shennong Bencao Jing [J]. National Med Forum , 2016 , 31 ( 5 ): 58 - 60 .
HE X , HE X , XU P , et al . Treatment with Radix Euphorbiae Ebracteolatae significantly decreases the expression of E6 and L1,and increases the expression of p53 and Rb in HPV18-infected human foreskin keratinocytes [J]. Curr Mol Med , 2019 , 19 ( 1 ): 20 - 31 .
FAN Z , WANG S , XU C , et al . Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation [J]. BMC Complement Med Ther , 2023 , 23 ( 1 ): 128 .
胡雅玉 , 任小丽 , 胡恩平 , 等 . PI3K和p-Akt在尖锐湿疣和生殖器鳞癌中的表达 [J]. 中国麻风皮肤病杂志 , 2012 , 28 ( 12 ): 850 - 853 .
HU Y Y , REN X L , HU E P , et al . The expression of PI3K and p-Akt in condyloma acuminatum and genital squamous cell carcinoma [J]. China J Lepr Skin Dis , 2012 , 28 ( 12 ): 850 - 853 .
XIE J , WANG S , LI Z , et al . 5-Aminolevulinic acid photodynamic therapy reduces HPV viral load via autophagy and apoptosis by modulating Ras/Raf/MEK/ERK and PI3K/Akt pathways in HeLa cells [J]. J Photochem Photobiol B , 2019 , 194 : 46 - 55 .
YARDEN Y , SHILO B Z . SnapShot:EGFR signaling pathway [J]. Cell , 2007 , 131 ( 5 ): 1018 .
杨亚玲 , 王婉润 , 张作良 , 等 . 基于EGFR/PI3K/Akt信号通路探讨加味少腹逐瘀汤治疗子宫内膜异位症的作用机制 [J]. 中国实验方剂学杂志 , 2025 , 31 ( 4 ): 29 - 38 .
YANG Y L , WANG W R , ZHANG Z L , et al . Mechanism of modified Shaofu Zhuyutang in treatment of endometriosis based on EGFR/PI3K/Akt signaling pathway [J]. Chin J Exp Tradit Med Form , 2025 , 31 ( 4 ): 29 - 38 .
COHEN R B . Current challenges and clinical investigations of epidermal growth factor receptor(EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma(HNSCC) [J]. Cancer Treat Rev , 2014 , 40 ( 4 ): 567 - 577 .
刘敏 , 史薇 , 杨菁 , 等 . 基于p53/Nrf2信号通路探讨新加苁蓉菟丝子汤对早发性卵巢功能不全大鼠颗粒细胞铁死亡的影响 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 7 ): 104 - 111 .
LIU M , SHI W , YANG J , et al . Xinjia Congrong Tusizi decoction regulates ferroptosis of granulosa cells in rat model of premature ovarian insufficiency via p53/Nrf2 signaling pathway [J]. Chin J Exp Tradit Med Form , 2024 , 30 ( 7 ): 104 - 111 .
DA SILVA J , DA COSTA C C , DE FARIAS RAMOS I , et al . Upregulated miRNAs on the TP53 and RB1 binding seedless regions in high-risk HPV-associated penile cancer [J]. Front Genet , 2022 , 13 : 875939 .
WANG H , GUO M , WEI H , et al . Targeting p53 pathways:Mechanisms,structures,and advances in therapy [J]. Signal Transduct Target Ther , 2023 , 8 ( 1 ): 92 .
LIN J , CHEN L , QIU X , et al . Traditional Chinese medicine for human papillomavirus(HPV) infections:A systematic review [J]. Biosci Trends , 2017 , 11 ( 3 ): 267 - 273 .
BIN C , ZHONG H , MO J , et al . Comparative efficacy and safety of Chinese patent medicines for cervical high-risk human papillomavirus infection:A bayesian network Meta-analysis [J]. J Cancer , 2023 , 14 ( 12 ): 2373 - 2385 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构